How Constellation Brands, Inc. Makes Money

The beer business sells Corona Extra, Corona Light, Modelo Especial, Modelo Negra, Pacifico, and Victoria in the United States, with Modelo Especial having become the #1 beer by dollar sales in U.S. Tracked channels. The Bud Light controversy in 2023 created a temporary opening for Modelo, but ABI has aggressively responded with pricing and marketing investments. The perpetual nature of the license means Constellation controls these brands in the U.S. Indefinitely, with the freedom to develop brand extensions and innovations. This brand equity commands pricing power: Constellation's beer portfolio sits in the high-end segment where consumers are less price-sensitive.

The number-one beer, period — displacing Bud Light after its 2023 controversy created an opening that Constellation exploited with distribution intensity and marketing that had been building for a decade. Canopy Growth's stock fell more than 90% from its peak. Constellation wrote down most of the investment. That growth is almost entirely beer. The Canopy investment saga consumed management attention and capital during years when the beer business needed focus. The debt-to-equity ratio stands at 133.57%, reflecting the use incurred to fund the Grupo Modelo acquisition and subsequent capacity investments, though the net use ratio of 2.9x remains below the company's target of approximately 3.0x. Constellation Brands generates revenue through two reportable business segments that operate at fundamentally different margin profiles and growth trajectories. The company has announced plans to divest remaining mainstream wine brands (those priced below $15), retaining only premium and luxury offerings. The key risk is that the wine and spirits impairments and Canopy Growth losses have destroyed billions in shareholder value, raising questions about capital allocation discipline. The competitive pattern is shaped by demographic trends: Hispanic population growth, premiumization preferences among millennials and Gen Z, and the decline of domestic light lagers. The problem is, Constellation's strategy of divesting mainstream brands and focusing on premium/luxury wines priced $15 and above positions it against Treasury Wine Estates' Penfolds and Gallo's higher-end offerings, but the market remains fragmented and promotional. The competitive threat from ready-to-drink cocktails and non-alcoholic alternatives is growing, with Constellation responding through innovations like Corona Sunbrew (non-alcoholic beer with vitamin D) and Modelo Spiked Aguas Frescas. These impairments reflect the declining value of acquired wine and spirits assets, including brands purchased at premium valuations during the 2000s acquisition spree. The third challenge is the Canopy Growth investment debacle. The company has been unwinding this position, but the financial damage is substantial and the strategic rationale — cannabis as the next growth frontier — has failed to materialize. Surprisingly, Pacifico's 20% growth is impressive but from a smaller base. Constellation's beer growth strategy rests on three levers: market distribution expansion in the 20 U.S. States where Modelo Especial has not yet achieved its full share potential relative to coastal and Sunbelt markets; the Modelo Oro and Corona Non-Alcoholic extensions that extend the franchise into the fast-growing better-for-you beer segment without cannibalizing core Especial and Extra volume; and route-to-market improvement through preferred distributor agreements that increase shelf presence and draft handle placement in on-premise accounts. The company was incorporated as Canandaigua Wine Company, Inc. In 1972 and completed its initial public offering in 1973, providing capital for the acquisition-driven growth strategy that would define the company for decades. In 1954, the company introduced Richard's Wild Irish Rose, a dessert wine that became its flagship brand and significantly expanded market presence. Between 2003 and 2008, the company executed a series of international acquisitions including BRL Hardy (Australia), Nobilo (New Zealand), Vincor International (Canada), and Beam Wines Estates, expanding its global wine footprint. In 2007, Spirits Marque One was acquired, bringing SVEDKA Vodka into the portfolio. This investment was predicated on cannabis legalization creating a massive new market, but regulatory delays, oversupply in Canadian cannabis, and Canopy's operational challenges produced billions in losses. In January 2025, the company completed the SVEDKA Vodka divestiture, and in April 2025 announced plans to divest remaining mainstream wine brands while retaining premium and luxury wines. The 1954 launch of Richard's Wild Irish Rose — a sweet, fortified wine priced for working-class consumers — gave the company its first national brand.